What is Acutis Biosciences?
Biomarker discovery experts elevating science excellence in precision medicine
Acutis Biosciences is a biomarker discovery provider to biopharmaceuticals with next-generation multi-omics biomarker analysis solutions powered by machine learning (ML) and AI.
With technology platforms in genomics and histopathology for the development and validation of state-of-the-art cancer molecular diagnostic assays, in oncology, immuno-oncology, and infectious diseases, Acutis redefines conventions with a unique customer engagement model combined with extraordinary science.
Committed to Life Sciences
We operate a CAP, CLEP, CLIA accredited 40,000-square-foot facility in New York,
a 60,000-square-foot state-of-the-art research facility in New Jersey,
and a technology center in Hyderabad India.
“We are reimagining biomarker discovery at the intersection of DNA, RNA, and protein diagnostics and are rewriting the rules to champion our biopharma partners. Far too often, we have heard about the industry’s dissatisfaction with CROs, whether it be slow turnaround time, incomplete data analytics, or missed opportunities to advance drug discovery with robust biomarker analytics”